Neuronal nicotinic acetylcholine receptor alpha-3 beta-4 subtype (alpha3beta4 nAChR)

The neuronal nicotinic acetylcholine receptor alpha-3 beta-4 (alpha3beta4) subtype is a heteropentameric ligand-gated ion channel primarily composed of alpha3 and beta4 subunits (NIH, 2020). It is the predominant nicotinic receptor in the autonomic ganglia and adrenal medulla, where it mediates fast excitatory synaptic transmission and regulates the release of catecholamines (Wikipedia, 2024). In the central nervous system, the alpha3beta4 subtype is localized in specific regions such as the medial habenula and interpeduncular nucleus, forming a critical part of the reward and aversion circuitry (Guide to Pharmacology). This receptor has gained significant attention as a therapeutic target for substance use disorders, particularly nicotine and cocaine addiction, due to its role in modulating drug-seeking behavior and withdrawal symptoms (Zaveri et al., 2010). Pharmacological agents targeting the alpha3beta4 receptor include agonists like nicotine and cytisine, as well as selective antagonists like AT-1001 and 18-methoxycoronaridine, which are being explored for their anti-addictive properties (NIH, 2020). Beyond addiction, the receptor is implicated in neuropsychiatric conditions and metabolic regulation, such as glucose tolerance (NIH, 2020). However, drug development faces challenges in achieving high subtype selectivity to avoid systemic autonomic side effects associated with its peripheral expression (Frontiers in Pharmacology, 2020).

Other names

alpha3beta4 receptoralpha3beta4 nicotinic receptorGanglion-type nicotinic receptorCHRNA3/CHRNB4 complexNeuronal acetylcholine receptor subunit alpha-3/beta-4

Agonist, Partial agonist, Antagonist, Non-competitive antagonist, Negative allosteric modulator